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Photoswitchable fluorescent proteins (PSFPs) that
change their color in response to light have led to
breakthroughs in studying static cells. However,
using PSFPs to study cells in dynamic conditions is
challenging. Here we introduce a method for in vivo
ultrafast photoswitching of PSFPs that provides
labeling and tracking of single circulating cells. Using
in vivo multicolor flow cytometry, this method
demonstrated the capability for studying recircula-
tion, migration, and distribution of circulating tumor
cells (CTCs) during metastasis progression. In
tumor-bearing mice, it enabled monitoring of real-
time dynamics of CTCs released from primary tumor,
identifying dormant cells, and imaging of CTCs
colonizing a primary tumor (self-seeding) or existing
metastasis (reseeding). Integration of genetically
encoded PSFPs, fast photoswitching, flow cytome-
try, and imaging makes in vivo single cell analysis
in the circulation feasible to provide insights into
the behavior of CTCs and potentially immune-related
and bacterial cells in circulation.
INTRODUCTION
Most cancer deaths are related to metastases in distant organs
due to disease dissemination by circulating tumor cells (CTCs)
shed from the primary tumor (Chaffer and Weinberg, 2011;
Christofori, 2006; Lazebnik, 2010; Fidler, 2003; Talmadge and
Fidler, 2010). Detection of CTCs appears to be a marker of
metastasis development, cancer recurrence, and therapy effi-
cacy (Alix-Panabie`res et al., 2012; Hayes and Smerage, 2010;
Attard and de Bono, 2011; Balic et al., 2013). Although substan-
tial efforts have beenmade to develop newmethods for studying
CTCs in vitro and recently in vivo (Alix-Panabie`res et al., 2012;
Hayes and Smerage, 2010; Attard and de Bono, 2011; Balic
et al., 2013; Georgakoudi et al., 2004; He et al., 2007; Galanzha
et al., 2009; Hwu et al., 2011; Yu et al., 2011), many aspects of
CTC dissemination, recirculation, migration, and final destination792 Chemistry & Biology 21, 792–801, June 19, 2014 ª2014 Elsevier(e.g., dormancy and self-seeding) remain poorly known (Alix-
Panabie`res et al., 2012; Attard and de Bono, 2011; Wicha and
Hayes, 2011). For example, it is not clear how long spontaneous
CTCs (i.e., naturally shed from a primary tumor or metastasis)
linger in circulation (referred to as CTC lifespan); how their life-
span depends on their biochemical, molecular, and genetic
properties; or how their lifespan correlates with metastasis pro-
gression. Answers to these and many other questions require
labeling single cells in the circulation to track their fate over a
long period. Despite its importance, this task cannot be accom-
plished by means of existing imaging techniques.
In particular, the use of genetically encoded fluorescent pro-
teins, such as green fluorescent protein (GFP), depicts all cells
expressing this protein, in particular bulk CTCs (Georgakoudi
et al., 2004). More specific molecular targeting, involving exoge-
nous labels bioconjugated with antibodies against a cell-surface
marker, can identify a specific subpopulation among bulk CTCs
(e.g., stem CTCs), but once inside the bloodstream, the bio-
conjugated labels can target many cells with the same marker
(He et al., 2007; Galanzha et al., 2009; Pitsillides et al., 2011).
To label and track individual cells and ultimately a single cell
in vivo, attention needs to be paid to new imaging and labeling
strategies.
Among many imaging agents, genetically encoded, photo-
switchable (called also photoconvertible) fluorescent proteins
(PSFPs) with controllable spectral shifts in excitation and emis-
sion in response to light offer a solution to this problem because
PSFPs are able to create unique cellular spectral signatures
(Kedrin et al., 2008; McKinney et al., 2009; Subach et al., 2011,
2012; Lombardo et al., 2012).
Applications of PSFPs such as green-to-red Dendra2 (Kedrin
et al., 2008), green-to-red mEos2 (McKinney et al., 2009),
orange-to-far-red PSmOrange (Subach et al., 2011), and
orange-to-far-red PSmOrange2 (Subach et al., 2012) have
already led to breakthroughs in the study of cell biology
in vitro. In addition, we have demonstrated the promise of
PSFPs for monitoring primary tumors in vivo (Kedrin et al.,
2008). However, to our knowledge, PSFPs have not been used
to detect CTCs because fast moving cells in vivo represent the
most challenging target for labeling and photoswitching. In
particular, the high velocity of CTCs prevents conventional pho-
toswitching of PSFPs (i.e., changing of their color), which typi-
cally takes 50- to 1,000-fold more time (e.g., 0.5–10 s) than theLtd All rights reserved
Figure 1. Principles of Multicolor PFC
(A) Schematic of the setup, together with signal
traces in the green and red channels before, dur-
ing, and after photoswitching (upper right inset)
and a diagram of the alignment of the laser beams
on the sample (lower right inset). CL, cylindrical
lens; DM, dichroic mirror; F, bandpass filter; AL,
achromatic lens; S, mechanical slit; PMT, photo-
multiplier tube, and PC, a computer.
(B and C) The underlying principle (B) and PFC
traces (C) of photoswitching and detection are
depicted.
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In Vivo Tracking of Single Circulating Cellslifetime (e.g., 10–30 ms) of CTCs in the detection volume (Tuchin
et al., 2011; Novak et al., 2004; Boutrus et al., 2007; Galanzha
and Zharov, 2012; Markovic et al., 2013). Because photoswitch-
ing time clearly depends on laser power and laser exposure time
(Subach et al., 2012), we suggest that photoswitching time can
be reduced by increasing the laser power level, with the total
energy deposition for the fast moving cells still remaining at a
safe level because of their short lifetime in the irradiated volume.
To minimize changes in surrounding static cells, the laser beam
can be strongly focused into blood vessels (i.e., moving cells in
blood flow) as we have previously reported (Galanzha and
Zharov, 2012).
Whereas a cell is labeled in circulation, it should be tracked
with a technique capable of monitoring millisecond-scale
dynamic events in fast blood flow at the single cell level in vivo.
Among awide range of in vivo imaging and detection techniques,
such as intravital microscopy, MRI, and positron emission
tomography, in vivo flow cytometry (FC) offers an impressive
example in which the blood vessels are used as natural tubes
for detection, among the native cells in flow, of rare CTCs, bac-
teria, clots, and other abnormal objects (Georgakoudi et al.,
2004; He et al., 2007; Galanzha et al., 2009; Pitsillides
et al., 2011; Tuchin et al., 2011; Novak et al., 2004; Boutrus
et al., 2007; Galanzha and Zharov, 2012; Nedosekin et al.,
2013). Two basic detection platforms of FC—fluorescenceChemistry & Biology 21, 792–801, June 19, 2014(Georgakoudi et al., 2004; He et al.,
2007; Hwu et al., 2011; Pitsillides
et al., 2011; Novak et al., 2004; Boutrus
et al., 2007) and photoacoustics
(Galanzha et al., 2009; Tuchin et al.,
2011; Galanzha and Zharov, 2012)—
have been explored separately and, re-
cently, together (Nedosekin et al., 2013)
with the use of intrinsic (e.g., melanin,
hemoglobin), genetically encoded (e.g.,
GFP), or exogenous (e.g., dyes or nano-
particles) labels. However, in vivo FC
has never been used to detect and photo-
switch PSFPs in circulating cells.
In view of the above considerations, the
problem of ultrafast photoswitching
could be solved by integrating in vivo FC
with a laser to photoswitch PSFPs, a
technique referred to below as a ‘‘photo-
switchable’’ flow cytometry (PFC).In this report, we introduce ultrafast photoswitching of genet-
ically encoded fluorescent proteins in individual circulating cells
and tracking of these cells in a whole organism in vivo. Using
CTCs, we demonstrate the capability of PFC for labeling a
controlled number of CTCs, potentially one cell, in blood flow
and tracking them over time, as well as for studying the lifespan,
recirculation, migration, and final destination of individual CTCs.
RESULTS
In Vivo Time-Resolved Multicolor PFC Platform
In PFC (Figure 1A), three continuous-wave lasers emit parallel
linear (10 mm3 80 mm) beams that are placed across the blood
flow, completely covering a vessel’s cross-section and not over-
lapping with each other (30 mm gaps). This setup allows
sequentially implementing four diagnostic procedures: (1) identi-
fying each nonphotoswitched CTC moving through the vessel
cross-section, (2) photoswitching (i.e., photolabeling) of this
cell, (3) detecting the photolabeled cell to control photoswitching
efficacy, and (4) tracking the photolabeled cell over time. Specif-
ically for CTCs genetically encoded with the Dendra2 PSFP, the
first laser at a wavelength of 488 nm excites the green fluores-
cence of Dendra2 (excitation, 488 nm; emission, 507 nm; Kedrin
et al., 2008; Figure 1B, top); the second laser at 405 nm induces
an irreversible shift in Dendra20s excitation and emissionª2014 Elsevier Ltd All rights reserved 793
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In Vivo Tracking of Single Circulating Cellsspectra >150 nm (i.e., photoswitching) so that the PSFP emits a
red fluorescence upon excitation (Figure 1B, middle); and the
third laser at 540 nm excites the photoswitched PSFP’s red fluo-
rescence (excitation, 540 nm; emission, 560 nm, Kedrin et al.,
2008; Figure 1B, bottom). To monitor and control these events,
the fluorescence from each cell is collected, detected, and re-
produced on a computer monitor as real-time signal traces in
two channels: green and red (Figure 1A, right, top). Thus, once
the cell is identified in the first (green) channel by a high-ampli-
tude signal (Figure 1C, top), it is immediately photolabeled, and
the change in its fluorescent color is detected when the signal
appears in the second (red) channel (Figure 1C, bottom).
The monitoring of multicolor signals also allows us to estimate
photolabeling efficacy and identify individual spectral signatures
(color fingerprints) of CTCs. Specifically, photoswitching (i.e.,
labeling) efficacy is estimated as the ratio of signal amplitudes
in the green and red channels before and after photoswitching.
If almost the entire amount of intracellular PSFP is photo-
switched (effective photolabeling) in a cell, the signal amplitudes
before (green channel) and after (red channel) photoswitching
can have similar values after the proper green and red channel’s
sensitivities are adjusted. Furthermore, the signal amplitude from
a PSFP-labeled cell reflects the cell’s fluorescence intensity
attributable to the amount of intracellular PSFP that depends
on an individual feature of a cell to express PSFP and, thus,
can be used to distinguish one CTC from another. Taken
together, the specific values of green signal amplitude before
photoswitching, red signal amplitude after photoswitching, and
their ratio at specific setup parameters represent an individual
spectral/color signature (fingerprint) for each CTC labeled by
PSFP and can be used to recognize individual CTCs in vivo. In
addition, the schematic with three nonoverlapping linear laser
beams provides the opportunity to measure the velocity (n) and
size of labeled objects (e.g., CTCs). Specifically, the temporal
width of the signal, which depends on the time (Dt1; Figure 1C)
it takes an object with certain diameter to pass the laser beam
(Georgakoudi et al., 2004; Galanzha and Zharov, 2012), was typi-
cally used to measure its size and thus distinguish single CTCs
(14–30 mm; Table S1 available online) from their aggregates
(>30 mm) and microparticles (<5 mm). To estimate velocity, we
measured the delay between signals in the green and red chan-
nels (Dt; Figure 1C) related to the time that it took a cell to travel
the distance Dd (Figures 1B and 1C) from the centerline of the
first laser (488 nm) to the centerline of the third laser (540 nm).
In the last case, the velocity is calculated as n = Dd/Dt. In our ex-
periments, most labeled CTCs had a velocity in the range of
0.7–3 mm/s, which is in line with data in the literature for circula-
tion in the mouse ear (Georgakoudi et al., 2004).
Selection of the PSFP for CTC Labeling
We compared three PSFPs, Dendra2, PSmOrange, and
PSmOrange2, using laser andmercury lamp light at wavelengths
of 405 nm and 488 nm to photoswitch Dendra2 and
PSmOranges, respectively. We determined that Dendra2 had
the fastest, most efficient photoswitching (Figure S1), which is
in line with previously reported results in vitro (Subach et al.,
2011). Because the kinetics and the degree of photoswitching
of both PSmOranges are highly dependent on the concentration
of oxidants in its environment (in the cuvette if in vitro or in the794 Chemistry & Biology 21, 792–801, June 19, 2014 ª2014 Elseviercytoplasm if in cells) and the total concentration of intracellular
oxidants typically does not exceed 250 mM, which is suboptimal
for PSmOrange photoconversion, the PSmOrange photoswitch-
ing in cells is rather inefficient (Subach et al., 2011). Thus,
Dendra2 was chosen for further studies.
Characterization and Photoswitching of Tumor Cells
Expressing Dendra2
Using highly metastatic carcinoma cells (MTLn3 adenocarci-
noma) expressing Dendra2 (Dendra2-MTLn3 cells), we demon-
strated that (1) culturing of Dendra2-MTLn3 cells do not cause
loss of fluorescence after many passages, and disappearance
of fluorescence is observed only in dead cells (Figure S2A); (2)
Dendra2-MTLn3 cells growing in an incubator (Figure S2B, left)
and CTCs extracted from amouse (Figure S2B, right) 21 days af-
ter inoculation with Dendra2-MTLn3 cells have similar brightness
that confirms stable expression of Dendra2 by the cancer cells
during proliferation in vivo; and (3) photoswitched (i.e., red)
Dendra2-MTLn3 cells growing in an incubator changed their
color to green after 48–72 hr proliferation (Figures S2C and S2D).
Taking into account these features, as well as the well-known
inability of moving cells to proliferate in the blood circulation, we
assume that all photoswitched CTCs will retain their switched
color (i.e., red for Dendra2) and can be distinguished from non-
photoswitched CTCs (i.e., green for Dendra2) until they are
dead or extravasate and proliferate in tissues.
At the next step, the 405-nm laser parameters were optimized
for photoswitching static Dendra2-MTLn3 cells in PBS (i.e., the
almost ideal condition for photoswitching). Fluorescence imag-
ing was used to quantify the changes in fluorescence. After
photoswitching, we obtained up to 182-fold increase in red fluo-
rescence, resulting in up to a 1,050-fold increase in the red/green
ratio of fluorescence intensities without essential photobleach-
ing or an effect on cell viability (Figure S3A and Table S2).
Notably, the total fluorescence from the same cell measured in
different focal planes slightly varied perhaps due to uneven
intracellular distribution of Dendra2 (Figure S3B). From this, the
repeatable detection of red fluorescence from the circulating
cells that change their orientation and position in flow can be
slightly different.
As expected, the presence of blood decreased both red and
green fluorescence. Nevertheless, photoswitching of Dendra2-
MTLn3 cells in the 120-mm thick sample of whole blood in static
conditions (i.e., approximately two times thicker than the diam-
eter of the blood vessels examined in the mouse ear) resulted
in an230-fold increase in the red/green fluorescence ratio (Fig-
ures S3C and S3D).
To optimize dynamic photoswitching of moving cells (mimic
CTCs), a slide with cells suspended in PBS and whole blood
(sample thickness 120 mm) was scanned with a 405-nm linear
laser beam at different velocities and laser power levels (Figure 2
and Figure S4). At beam velocities in the range of 1–3 mm/s (ex-
pected cell velocity in mouse ear vessels), optimal photoswitch-
ing was achieved at a laser power of 10–30mW. In particular, the
photoswitching of cells in PBS, moving at 1 mm/s at a laser
power of 30 mW (power intensity at the sample 3 3
103 W/cm2), led to a 70-fold increase in the red/green fluores-
cence ratio (Figures S4A and S4B). The chosen parameters
(e.g., laser power of % 30mW) did not cause photobleachingLtd All rights reserved
Figure 2. Photoswitching of Cancer Cells in Whole Blood In Vitro
Schematic (A), images (B), and normalized fluorescence (C) in cancer cells moving with a velocity of 1 mm/s across a linear laser beam having a power of 30 mW.
Error bars represent SEM; data were collected from 15 cells (C).
See also Figures S2, S3, and S4.
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In Vivo Tracking of Single Circulating Cellsbecause of the short cell-exposure time (a few milliseconds;
Figure S4A). Photoswitching of moving cancer cells in a
120-mm thick layer of whole blood at the indicated above param-
eters increased the red/green fluorescence ratio 40-fold (Fig-
ure 2). Despite the predictable loss of photoswitching contrast
against the background signals of blood, fluorescence micro-
scopy clearly distinguished photoswitched from nonphotos-
witched cells in the blood (Figure 2B). Based on these results,
we can conclude that effective photoswitching can be
achieved in selected animal models in blood vessels with a
diameter% 100–120 mm at a flow velocity up to 1–3 mm/s.
In Vivo Photoswitching Optimization
In healthy mice, we explored whether irradiation of 405-nm laser
affects the functions of ear blood vessels. Based on the results
above and previous data (Lombardo et al., 2012), we tested
power level in the range of 20–40 mW, which is appropriate for
photoswiching of Dendra2. From our observations, all vessels
had good blood flow before and after photoswitching, and no
mice exhibited blood flow stasis (Movie S1). Only one mouse
showed a temporary 50%–60% constriction of an irradiated
vessel after a 10 min exposure to the 405-nm laser at a power
of 38 mW. To reduce the risk of such effects in the experimental
mice, we kept the laser power at %30 mW and carefully
controlled blood flow stability with video recording. Then, we
estimated background autofluorescence from blood irradiated
by 488-nm and 540-nm lasers. In analogy to Lin’s study (Georga-
koudi et al., 2004; Boutrus et al., 2007), a signal-amplitude
threshold in each channel was determined as the mean and an
increment of the SD (typically five SDs) of the background signal.
The intact ear skin without visible vessels provided a background
autofluorescence-to-noise ratio% 3. Variations in the autofluor-
escence background frommouse to mouse and day to day were
not significant for vessels of the similar size, at least within the
established signal threshold. Signals having a higher amplitude
than this threshold were considered to be associated with CTCs.
Injection of nonphotoswitched (green) and photoswitched
(red) Dendra2-MTLn3 cells (23 105 cells per injection) showed
that PFC detected CTCs with a signal-to-background noise ratio
up to 15 (Figure S5). In addition, both, green and red fluorescent
cells exhibited similar dynamic rates after injection, which
allowed an estimation of PFC’s sensitivity. Although the maximal
number of CTCs per minute varied from mouse to mouseChemistry & Biology 21,because of individual injection conditions and distribution of
cells in the body, we could detect an average of up to 18
CTCs/min in vessels with a mean diameter of 52 ± 5 mm. This
was close to the theoretical estimation of up to 24 CTCs/min in
a 50-mm diameter vessel at a velocity of 2 mm/s after the intro-
duction of 2 3 105 cells.
Labeling and Tracking of Single CTCs In Vivo
For proof-of-principle implementation, nonphotoswitched
(green) cells were injected into mice and monitored with PFC
(Figure 3A). When the rate of cells became rare and relatively
stable at a level of 1–3 CTCs per minute (25–30 min after injec-
tion), we photoswitched single CTCs by turning on a 405-nm
laser at the power of 30 mW (power intensity on the vessel 3 3
103W/cm2). During photoswitching, blood flow and vessel diam-
eter were monitored by video-recording (Movie S1), and CTC
velocity was controlled as described above. All photoswitched
CTCs had velocity ranging from 1 to 2 mm/s.
Using a PFC platform, we were able to photolabel the desired
number of CTCs, even just one cell. For example, Figure 3
(25 min after cell injection; 1.5 ± 0.7 green CTCs/5 min) shows
the photoswitching of three CTCs. Each CTC created an individ-
ual fingerprint (purple rectangles in Figures 3B and 3C) that can
be defined as the ratio of green signal amplitude before photo-
switching to red signal amplitude after photoswitching. The value
of red signal amplitude was used to later identify these cells in
circulation (Figures 3B and 3D). Specifically, CTC 1 had a signal
amplitude of 2.7 arbitrary units (a.u.) in the green channel before
photoswitching and a signal amplitude of 2.5 a.u. in the red chan-
nel after photoswitching. This means that the green-to-red fluo-
rescence signature (fingerprint) for CTC 1 was 2.7/2.5. Similar
amplitude values before and after photoswitching (difference
of %10%) allowed us to conclude that labeling was effective.
CTCs 2 and 3 were also effectively labeled with fingerprints of
5.0/4.8 and 4.7/4.4, respectively. Continuous 90 min monitoring
demonstrated that the CTCwith a red amplitude of2.5 a.u. (i.e.,
CTC 1) did not repeat its appearance at the detection point, while
CTCs 2 and 3 were monitored again at the point of detection
within 30–40 min. Unexpectedly, the CTC with a red amplitude
of 4.4 a.u. (i.e., likely CTC 3) appeared before the CTC with a
red amplitude of 4.8 a.u. (i.e., likely CTC 2), suggesting that
CTCs, like normal white blood cells, may use different trafficking
pathways (Gowans and Steer, 1980; Halin et al., 2005).792–801, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 795
Figure 3. In Vivo Photolabeling and
Tracking of Individual CTCs
(A and B) Diagram of the experiment (A) and traces
of three CTCs with different fingerprints (B).
(C) Effective photoswitching and fingerprint crea-
tion for CTC 3 (velocity, 1.7 mm/s).
(D) Recognition of CTC 3 based on its fingerprint.
See also Figure S5 and Movie S1.
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In Vivo Tracking of Single Circulating CellsThus, we demonstrated the potential to fingerprint CTCs.
However, in some cases, the value of the CTC signal amplitude
in the red channel was not exactly the same at the repeated
crossing of the detection laser as it was when measured after
photoswitching. This presented a challenge. Based on our
in vitro tests (Figure S3B) and previous results (Novak et al.,
2004), this finding may be due to a change in the axial location
and/or orientation of the moving cell (Novak et al., 2004).
Although the differences in amplitude in our experiments did
not exceed 5%–10%, this issue requires additional study before
fingerprinting can be routinely used in experimental studies.
Additionally, although this pilot study demonstrated the labeling
of single CTCs after intracardiac injection, we did not see any
difficulties in using PFC for tumor-bearing mice. Thus, this
method would help to answer the question of how the lifespan
of spontaneous CTCs correlates with their metastatic potential
and the progression of metastatic disease.
Real-Time Shedding of CTCs from Primary Tumor
To test the capability of fast photoswitching and PFC for
advanced study of metastatic disease and naturally shedding
(i.e., spontaneous) CTCs, we first developed a mouse ear model
of metastatic carcinoma (Figure 4 and Figure S6). This model
offers a few advantages. First, the relatively isolated location of
the primary tumor from other parts of the body allows successful
laser photoswitching without undesirable irradiation of other
organs with possible metastasis (e.g., lymph nodes, brain, liver,
lungs). Second, the thin (250 mm), relatively transparent ear
structure allows noninvasive optical imaging (Figures 4A and
4B) to control tumor development and photoswitching. Third,
CTCs appear early, starting from day 5 after tumor inoculation,
disseminate by both blood and lymphatic pathways, and the
development of multiple metastases follows (Figure 4C, Figures
S6A–S6F, and Supplemental Experimental Procedures). With
this model in hand, we define the in vivo process by which tumor796 Chemistry & Biology 21, 792–801, June 19, 2014 ª2014 Elsevier Ltd All rights reservedcells are released from a primary tumor
into blood circulation. We photoswitched
a primary tumor (Figure 5A) in four mice
and performed real-time monitoring of
CTCs in the blood circulation before, dur-
ing, and after photoswitching. The effi-
ciency of ear-tumor switching was easily
controlled with fluorescence imaging
(Figure 5A, bottom). As expected, before
photoswitching of the primary tumor, all
CTCs were green (i.e., only green signals
were detected with PFC; Figure 5B). The
green-to-red photoswitching of the pri-
mary tumor caused the appearance ofred signals in the PFC traces (Figure 5B, bottom) that were asso-
ciated with ‘‘new’’ CTCs just shed from the primary tumor.
We found that an advanced carcinomawas able to release 3–7
CTCs per 4–6 hr and the process of CTC shedding was charac-
terized by temporal irregularity. As shown in Figure 5B, for
example, the first ‘‘new’’ CTCs (red) were detected only
at 180 min after photoswitching, and three of them appeared
almost simultaneously. Notably, this triplet of ‘‘new’’ CTCs was
recognized by PFC as single cells not as aggregates. Later,
at 50 and 120 min after the first group, we monitored the
next two red CTCs. Thus, we monitored in real time the dynamic
process of the appearance of CTCs in circulation after their
spontaneous shedding from primary tumor.
Dormancy, Self-Seeding, and Reseeding
Finally, we exploredwhether PFC can study dormancy (coloniza-
tion of metastatic sites by CTCs without proliferation) and self-
seeding (return of CTCs to the primary tumor; Kim et al., 2009;
Langley and Fidler, 2007; Townson and Chambers, 2006; Klein,
2011). In mice with ear tumors (Figure 6A), we photoswitched
CTCs in a tail vein with a 405-nm laser. The reason for using a
tail vein is to exclude irradiation (i.e., undesired photoswitching)
of both the primary tumor and metastases throughout the body.
Despite stronger scattering of laser light in the tail skin and higher
blood velocity in tail vessels, as compared to the ear model, the
PFC, which followed the photoswitching procedure, revealed
44% ± 5% of signals in the red channel (Figure 6B), indicating
that approximately half of bulk CTCs were photolabeled. In
some cases, photoswitching was incomplete, and CTCs emitted
signals in the red channels (white arrows in Figure 6B) with two to
three times lower amplitude than in the green channel before
photoswitching. Nevertheless, the number of labeled CTCs
was sufficient to distinguish these cells after they were extrava-
sated into intact tissues, primary tumor, or existing metastases
(Figures 6C–6E). For example, the cells that had 15–70 times
Figure 4. In Vivo Monitoring of Primary Tumor and CTCs in Mice with Metastatic Carcinoma
(A) Photo of the ear tumor and combined fluorescence-transmission microscopic image of the tumor area of interest (inset).
(B) Imaging of intratumor vessels and intravascular rolling of a CTC (inset).
(C) CTC kinetics in mice bearing ear tumors (n = 7). In vivo measurements at the final point of tumor development were verified by fluorescent imaging of blood
samples in vitro (inset). Error bars represent SEM.
See also Figure S6.
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In Vivo Tracking of Single Circulating Cellshigher red fluorescence than autofluorescence of liver, brain,
and lymph nodes and did not proliferate for up to 9 days were
associated with dormant cells (Figure 6C and Figures S6G and
S6H). We also imaged rare red fluorescent cells within green tis-
sue of a primary tumor that were associated with self-seeding of
the primary tumor (Figure 6D). Self-seeding CTCs exhibited up to
52-fold increased red fluorescence compared to the surrounding
tumor mass. The 15–30 mm diameter of red cells additionally
confirmed their relation to cancer cells (Table S1). Using the
same methodology, we unexpectedly identified red fluorescent
cells inside a green metastasis (Figure 6E), providing direct
evidence of the colonization of the existing metastatic sites by
CTCs (reseeding phenomenon).Chemistry & Biology 21,DISCUSSION
We developed a method for labeling a controlled number of
circulating cells (e.g., CTCs) and, potentially even one cell,
through ultrafast photoswitching (10–50 ms [PFC] versus
1–10 s [existing methods]) directly in the bloodstream in vivo
for the purpose of tracking these labeled cells within whole ani-
mals; this capability is beyond the scope of current labeling
and detection methods.
Our method is based on a technological platform termed PFC
and in vivo ultrafast photoswitching of circulating cells geneti-
cally encoded with PSFPs. Notably, circulating cells in vivo
represent the most challenging target for photoswitchingFigure 5. Tracking CTCs Spontaneously
Shedding from the Primary Tumor
(A) Workflow diagram for studying the real-time
dynamics of the release of CTCs from a primary
tumor after it is photoswitched.
(B) Green and red fluorescence traces recorded in
a 56-mm diameter vein shows dynamic of CTC
shedding from a primary tumor. Green signals
correspond to nonswitched (‘‘old’’) CTCs,while the
red signals indicate photoswitched (‘‘new’’) CTCs.
792–801, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 797
Figure 6. Dormacy, Self-Seeding, and Reseeding
(A and B) Workflow of photoswitching of CTCs in a tail vein (A) and monitoring
CTCs in the green and red channels (B); the white arrows indicate the signals
from a partly switched CTC.
(C) Combined, transmission and fluorescence, image of the dormant cell in
liver (day 9 after CTC photoswitching); the red fluorescence of the dormant cell
is 18-fold higher than the autofluorescence of an intact liver.
(D and E) Combined images from the green and red fluorescence channels of
self-seeding (D) and reseeding (E) cells with a 48-fold and 77-fold, respectively,
increase of red fluorescence compared to a green primary tumor or existing
metastasis; visible vessels indicated by white dotted lines.
See also Figures S2 and S6.
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In Vivo Tracking of Single Circulating Cellsbecause multiple undesirable factors cannot be excluded, such
as light scattering in skin, autofluorescence of the blood back-
ground, and the high velocity of moving cells. Nevertheless, in
studies in vivo, we demonstrated sufficient sensitivity and spec-
ificity of our method to effectively label a single CTC and suc-
cessfully recognized the labeled cell from nonphotoswitched
PSFP-expressing cells, as well as from other cells in circulation.
Among different PSFPs and various biomedical applications of
PFC, we used carcinoma cells with Dendra2 PSFP to demon-
strate the capability of this method to enhance CTC-related
research. Subsequent in vitro and in vivo experiments allowed
us to estimate the optimal parameters for lasers and vessels
(e.g., laser energy, range of vessel diameters, and flow velocity)
for effective photoswitching of Dendra2 in cancer cells against
the background of blood. To minimize possible photodamage
of surrounding tissues, the laser beams were strongly focused
into blood flow to ensure a short thermal relaxation time and
hence more effective cooling of the heated localized zone.
As a result, we developed a protocol for implementing four
procedures: (1) identifying each nonphotoswitched Dendra2-
CTC crossing the first laser beam, (2) photoswitching (i.e., photo-
labeling) it while it moves through the second laser beam, (3)
detecting the photolabeled CTC to control photoswitching effi-
cacy when it crosses the third laser beam, and (4) tracking the
labeled (red fluorescent) CTC(s) over time. Thus, the key advan-798 Chemistry & Biology 21, 792–801, June 19, 2014 ª2014 Elseviertage of PFC is its ability to photolabel a single cell to create a
unique light-activated fluorescent signature for that cell while it
circulates within a whole organism in vivo. This allows CTC
behavior to be continuously tracked in its natural environment
under the complex regulation of a whole living organism. In addi-
tion, PFC can yield information on the velocity and number of
CTCs, as well as information on the size of labeled objects that
allows us to distinguish single CTCs from their aggregates and
fragments (e.g., microparticles).
In tests in vitro, we ascertained that (1) CTCs with Dendra2
retain bright fluorescence for many days in vivo if they are not
dead, and (2) photoswitched (red) CTCs can become green
only when they proliferate. From these results, we concluded
that (1) individual viable CTCs switched in flow can be distin-
guished from bulk CTCs, until they leave the circulation; and (2)
photoswitched CTCs that extravasate into tissue and do not pro-
liferate will retain their switched color (i.e., red for Dendra2).
These features of the cells with PSFPs represent an advanced
way to track CTCs and study their shedding, recirculation,
migration, and destination.
For the first time, we showed that some CTCs (not all) may re-
circulate quickly and repeatedly appeared at the detection point
within 30min. Such a scenario is possible, given that CTCsmove
relatively slowly at a velocity of a few millimeters per second in
small blood vessels, and, then, their motion is dramatically
accelerated in central circulation to achieve velocity of
23 cm/s in the mouse aorta at a cardiac output of 14–15ml/min
(Hartley et al., 1995; Hedrich, 2004). We cannot exclude that
CTCs, like lymphocytes (Gowans and Steer, 1980; Halin et al.,
2005), may recirculate locally using the bridges between the
arterial and venous systems (arteriolovenular anastomoses;
Schmidt and Carmeliet, 2010) and/or a network of lymphatic
vessels. The latter pathway is quite possible becausewe demon-
strated the ability of carcinoma CTCs to disseminate via periph-
eral lymph vessels (Figure S6F). Our future studies will be
directed to understand the process and purpose of CTC recircu-
lation for the development of metastatic disease.
PFC has considerable potential to measure the lifespan of
spontaneous CTCs and define correlations between CTC life-
span and metastatic progression. This, for example, would
help clarify whether a decrease in the number of CTCs observed
during disease progression is the result of a shortened lifespan
with accelerated extravasation into target organs or shedding
from the primary tumor at a lower rate. Such knowledge would
be important for judging clinical prognosis because these mech-
anisms are related to alternative scenarios of disease develop-
ment: the first by possibly facilitating themetastasis progression,
and the second by possibly indicating regression of this process.
If CTC lifespan strongly correlates with metastatic progression,
then the lifespan of CTCs can be used as a biomarker of disease
prognosis. Hypothetically, in line with the concept of parallel pro-
gression of primary tumor and metastasis (Klein, 2009), we
expect to find shorter lifespans for CTCs during the initial stages
of disease when CTCs actively colonize new metastatic sites.
Our results demonstrated that PSFPs and PFC are useful for
uncovering new knowledge on the real-time dynamics of CTC
shedding from primary tumors. Using PFC with the photoswitch-
ing of a primary tumor, we observed that an advanced carcinoma
sheds CTCs at the relatively low rate of a few cells per 4–6 hr.Ltd All rights reserved
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In Vivo Tracking of Single Circulating CellsAlthough it is currently too early to make conclusions about the
generality of this phenomenon, our results demonstrated ameth-
odological solution to studying the dynamics of CTC renewal that
might be applied to various tumors at different stages. We also
found that the rate of shedding CTCs varied over time. These
temporal fluctuations seem to be significant for CTC diagnosis
in patients because, for instance, they can explain false-negative
results of a one-time snapshot test. Our recent clinical studies
indirectly confirmed the dynamic fluctuation of CTCs in circula-
tion (Juratli et al., 2014). In three blood samples taken at different
times from the same patient with metastatic melanoma, we
detected different numbers of CTCs. Moreover, these results
are in line with previous data obtained in animals: different
numbers of CTCs were found in blood samples taken at different
times from the same mouse (Glaves et al., 1988).
Labeling of CTCs with PSFPs also offers a relatively simple
approach to studying the phenomena of self-seeding at the sin-
gle cell level. Moreover, our findings showed that some CTCs
were able to colonize existing metastases. The role of such re-
seeding is yet unclear and requires clarification in future studies.
PFC improves the quantification of bulk CTCs. Indeed, when
researchers previously detected CTCs with in vivo flow cytome-
try (Georgakoudi et al., 2004; He et al., 2007; Galanzha et al.,
2009; Hwu et al., 2011; Pitsillides et al., 2011), they could never
be certain whether they had detected the same CTCs returning
to the detection point or newly shed cells. PFC with PSFP-
labeled cells can prevent repeated counting of CTCs by the
switching of previously detected cells, thus providing more
accurate quantification of CTCs.
The flexibility of the technical platform (e.g., easy replacement
or addition of lasers) makes this approach universally applicable
for detecting various PSFPs. We also expect a further leap for-
ward when photolabeling of CTCs is combined with molecular
labeling. Technically, this can be achieved by injection of
nanoparticles and/or fluorescent dyes bioconjugated with
CTC-specific biomarkers (e.g., antibodies) into the circulation
and then detection of specific molecular profiles of photo-
switched and nonphotoswitched CTCs with the use of
combining fluorescence and photoacoustic FC in vivo that we
recently developed (Nedosekin et al., 2013). Integrated labeling
of CTCs with PSFPs and bioconjugated nanoparticles would
clarify the in vivo interrelationships between CTC lifespan,
molecular profiles, and metastasis progression. The molecular
signatures of CTCs with different lifespans could be estimated
and expected to be different. The molecular patterns of gene
expression characterizing tumor-initiating properties, epithelial-
mesenchymal transition, and high migration activity will likely
be found inmicemodels, in which the lifespan of CTCs is shorter.
This approach will also define how the in vivo behavior of CTCs
correlates with biochemical processes in them, including
oxygenation and processes responsible for cell migration. For
example, labeling of calcium and/or transient receptor potential
channels that modulate intracellular calcium concentration and
contribute to cancer cell migration (Fiorio Pla and Gkika, 2013)
would instantly facilitate exploring the role of transient receptor
potential channels in CTC shedding into the circulation.
A limitation of the current setup related to the incomplete pho-
toswitching of CTCs in large vessels could be overcome by
replacing the continuous-wave laser with a pulsed laser. Opti-Chemistry & Biology 21,mized pulse exposure triggering by signals from the first (green)
channel would significantly improve photolabeling efficacy and
decrease tissue photodamage. As shown in the three-beam
schematic (Figure 1B), immediately after photoswitching cells
can be detected using the red channel only, whereas their
detection simultaneously in two (green-red) channels can be
performed after they come back to detection point.
In general, PFC can be broadly applied for studying any solid
metastatic tumor (e.g., breast, ovarian, prostate, or melanoma)
and for determining tumor cell dissemination in hematologic
malignancies (e.g., leukemia or multiple myeloma). Moreover,
single cell photolabeling can uniquely trace the fate of any circu-
lating cell or group of cells of interest in different animal models
to discover and assess various physiologic and pathologic
processes related to health and disease, including immune func-
tion, bacteremia, sepsis, and clotting. In the future, this knowl-
edge could help in developing advanced diagnostic techniques
and individualized therapy.SIGNIFICANCE
Our work presents a technical approach for the analysis of
single circulating cells in vivo that integrates photolabeling
of individual cells directly in the bloodstream and tracking
of the labeled cells over time. Specifically, our technology
provides a noninvasive, ultrafast photolabeling of single
circulating cells in vivo using genetically encoded photo-
switchable fluorescent proteins (PSFPs), which change their
fluorescent color (e.g., from green to red for Dendra2) in
response to light irradiation. This approach has been shown
to be capable of the efficient labeling and tracking single
circulating tumor cells (CTCs) in tumor-bearing mice to
study dynamic processes of the CTC recirculation, migra-
tion, distribution, and final localization.EXPERIMENTAL PROCEDURES
Schematics of the Multicolor PFC Platform
The system (Figure 1A) is based on an Olympus IX81 inverted microscope
(Olympus America) with incorporated three continuous-wave lasers: (1)
wavelength, 488 nm; power, 1 mW at the sample (IQ1C45[488-60]G26, Power
Technology); (2) 540 nm (He-Ne; power, 0.17 mW at the sample, Research
Electro-Optics); and (3) 405 nm (continuous-wave diode); power, up to
40 mW at the sample (IQu6C225[405-500S]/8726, Power Technology).
As shown in Figure 1A, a cylindrical lens created a linear beam con-
figuration measuring 10 mm 3 80 mm for each laser. A 403 objective
(Olympus America) with a numerical aperture (NA) of 0.65 was used to focus
light from each of the three lasers onto a mouse ear blood vessel with a
depth of focus of 60 mm, matching the vessel’s diameter (50–60 mm).
The same micro-objective collected the emitted fluorescence from each
cell. To operate the three lasers (focusing, collecting fluorescence) with
one objective, the laser beams were filled full NA of the objective and
were displaced from the main microscope axis as indicated in Figure 1A
(lower right inset). Collected fluorescence passed through bandpass filters
(520 ± 15 nm for the 488-nm laser and 580 ± 15 nm for the 540-nm laser),
achromatic lenses, and slits (200 mm 3 3 mm) and was then detected with
two photomultiplier tubes (PMTs; model R928, socket HC123-01; Hama-
matsu) and recorded with a computer equipped with a high-speed (200
MHz) analog-to-digital converter board (PCI-5152, 12-bit card, 128-MB
memory; National Instruments). PMT signals were continuously sampled
at a rate of 4 MHz and down-sampled to a 10-kHz rate, with 400 points
on average being sampled. The resultant traces were displayed on the792–801, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 799
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In Vivo Tracking of Single Circulating Cellscomputer monitor in real time (Figure 1A, upper right inset). Custom software
(LabVIEW; National Instruments) was used for off-line processing of saved
traces and calculating amplitudes, locations, and peak widths exceeding
the background level.
For video-recording of blood flow in vivo, as well as imaging of tissue sam-
ples or cell suspensions ex vivo/in vitro and primary tumor in vivo, the micro-
scope was equipped with a cooled color CCD camera (DP72, Olympus) and a
black-and-white, high-speed, highly sensitive CCD camera (Cascade:512;
Photometrics/Roper Scientific). Images were obtained in either transmission
mode or fluorescence mode with two emission filters (530 ± 30 nm and
590 ± 30 nm) and a variety of objectives with magnifications ranging from
43 to 403 in vivo and from 103 to 1003 (oil immersion) ex vivo/in vitro. The
same exposure time was applied for the same sample before and after photo-
switching for green and red fluorescence. Images were acquired and
combined (if necessary) at a workstation and processed with the use of Adobe
Photoshop 7.0.1 software (Adobe Systems) and ImageJ 1.46 for Windows
(available at http://rsb.info.nih.gov/ij/).
In Vitro Photoswitching
The PSFPs Dendra2 and the PSmOranges were photoswitched in solution
and in cells with, respectively, 405-nm and 488-nm wavelength diode lasers.
A linear laser beam configuration was used to photoswitch the cells in a
120-mm thick, 8-mm diameter well (S-24737; Molecular Probes/Life Tech-
nologies) attached to a microscope slide. To photoswitch a large number
of cells in suspension (e.g., for in vivo injection) in a cuvette or cells
proliferated in a dish, the laser spot was defocused by a ground-glass
diffuser, which resulted in a 15-mm diameter beam that was comparable
to the size of the cuvette/dish. In some comparative tests, PSFP suspen-
sions were photoswitched with a mercury lamp and the use of excitation fil-
ters of 387 ± 6 nm and 520 ± 15 nm for Dendra2 and PSmOranges,
respectively.
Fast photoswitching of moving cells in vitro was modeled by scanning
Dendra2-MTLn3 cells in a well with a two-dimensional (X-Y) translation stage
(H117 ProScan II; Prior Scientific) with a positioning accuracy of 50 nm.
Photoswitching Efficacy
The efficacy of photoswitching CTCs in the blood circulation in vivo was
estimated by comparison of signal amplitudes from the CTCs before photo-
switching (green channel) and after photoswitching (red channel). Photo-
switching cells ex vivo/in vitro were quantified by fluorescent imaging with
the use of ImageJ 1.46 software. In particular, we measured both green
and red fluorescence as the total fluorescence in the same cell(s) before
and after photoswitching after subtracting background signal from surround-
ing solution, blood, or tissue. The value of green fluorescence was normal-
ized to the initial fluorescence level (before photoswitching), whereas the
value of red fluorescence was normalized to the highest fluorescence level
after photoswitching. We also calculated the non-normalized ratio of red-
to-green fluorescence intensity (red/green ratio).
PSFPs and Mammalian Cells
Recombinant Dendra2, PSmOrange, and PSmOrange2 cells were expressed
in bacteria and purified as previously described (Kedrin et al., 2008; Subach
et al., 2011, 2012). The PSFP stock solution was diluted with PBS to 3 mM,
which approximately corresponded to its concentration in the cytoplasm of
stably expressing cells. The solution of each protein was mixed with inert
optical transparent oil and rigorously shaken to prepare small drops of PSFPs,
which were placed on slides for further study.
The MTLn3 adenocarcinoma cells, originally isolated by Neri and Nicolson
(Institute for Molecular Medicine, Huntington Beach, CA), were maintained in
a-minimum essential medium (Invitrogen/Life Technologies) with 5% fetal
bovine serum and penicillin-streptomycin (Invitrogen/Life Technologies). A
preclonal mixture of MTLn3 cells expressing Dendra2 was used in all experi-
ments. Viable cells were resuspended in PBS to the desired concentration.
Animal Models
Animals were used in accordance with a protocol approved by the University
of Arkansas for Medical Sciences Institutional Animal Care and Use Com-
mittee. Nude mice (nu/nu), 8–10 weeks old, weighing 20–30 g, were procured800 Chemistry & Biology 21, 792–801, June 19, 2014 ª2014 Elsevierfrom a commercial source for use in the experiments. The animals were
anesthetized by isoflurane and placed on a heated microscope stage (at
38C [body temperature]).
Control measurements were performed (1) on intact vessels (mean diam-
eter, 51 ± 6.5 mm) in eight healthy mice and (2) on the vessels before any injec-
tion or inoculation in experimental groups of mice. For a valid comparison of
the data, PFC was performed in accordance with the same parameters (laser
power, monitoring time, etc.) on vessels of similar diameters to those in the
experimental groups. In addition, tissue samples from healthy mice were
used to estimate autofluorescence level in microscope images.
To photoswitch individual cells, 23 105 Dendra2-MTLn3 cells resuspended
in 50 ml of PBSwere introduced into themouse circulation through intracardiac
injection into the left ventricle.
To create a primary tumor with metastatic dissemination (see Supplemental
Experimental Procedures), mice (n = 8) were inoculated with 13 106 Dendra2-
MTLn3 cells in an ear. The mice were examined weekly with (1) PFC and (2)
intravital fluorescence imaging of the inoculated ear to estimate the develop-
ment of primary tumors (e.g., size, vascularity), and (3) whole-body imaging
with an IVIS Spectrum imaging system (Caliper Life Sciences) to define the
appearance of overt metastases. In one subgroup of tumor-bearing mice
(n = 4), primary ear tumors (30 days after inoculation) were switched with an
unfocused 405-nm laser (spot size, 20 mm; laser power, 30 mW; exposure,
3–5 min). During photoswitching, the ear was isolated from other parts of the
mouse body by a foil. Fluorescence imaging was used to control the efficacy
of switching and avoid overexposure. In a second subgroup (n = 4), the mice
underwent photoswitching of CTCs in tail veins (exposure,5min). To prevent
possible overheating, the irradiated skin area was cooled with a customized,
optically transparent cooler.
Blood Sampling and Tissue Isolation for Ex Vivo Tests
At the end of the in vivo studies, blood and multiple organs (e.g., liver, lymph
nodes, lungs, and brain) were extracted for examination. Samples of whole
blood were placed in 120-mm thick wells and tissue samples in 1-mm thick
wells (both from Molecular Probes) attached to slides for ex vivo/in vitro
imaging.
To optimize photoswitching, fresh stabilized whole blood was obtained from
healthymice and spikedwith of Dendra2-MTLn3 cells at a concentration of 23
106 cells per 1 ml of blood, which is close to the real situation in blood circula-
tion in vivo because carcinoma can shed up to 3–4 3 106 CTCs (Butler and
Gullino, 1975) and the total volume of mouse blood is 2 ml.
Statistical Analysis
MATLAB 7.0.1 software (The MathWorks) was used for statistical analyses.
Results were expressed as means ± SEM of at least three independent exper-
iments. A p value < 0.05 indicated a significant difference.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, two tables, and one movie and can be found with this article online
at http://dx.doi.org/10.1016/j.chembiol.2014.03.012.
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